InterCure's CEO sees the acquisition of Leon Pharm as a move...
InterCure's CEO sees the acquisition of Leon Pharm as a move towards implementing new medical cannabis reform and catering to unique patient needs in Israel. This is expected to bolster InterCure's market dominance.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002222a61bb62a1a.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment